GENESYS RES INST has a total of 13 patent applications. Its first patent ever was published in 2013. It filed its patents most often in WIPO (World Intellectual Property Organization), Canada and EPO (European Patent Office). Its main competitors in its focus markets pharmaceuticals, biotechnology and foods and drinks are EVOX THERAPEUTICS LTD, ANERGIS S A and CYTAVIS BIOPHARMA GMBH.
# | Country | Total Patents | |
---|---|---|---|
#1 | WIPO (World Intellectual Property Organization) | 5 | |
#2 | Canada | 3 | |
#3 | EPO (European Patent Office) | 3 | |
#4 | United States | 2 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Foods and drinks | |
#4 | Environmental technology |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds | |
#3 | Peptides | |
#4 | Climate change adaptation technologies | |
#5 | Enzymes | |
#6 | Microorganisms |
# | Name | Total Patents |
---|---|---|
#1 | Yan Xinhua | 5 |
#2 | Morgan James P | 4 |
#3 | Cantley Lewis C | 4 |
#4 | Abou-Slaybi Abdo | 3 |
#5 | Klement Giannoula Lakka | 3 |
#6 | Parker Mark A | 3 |
#7 | Edge Albert | 3 |
#8 | Bhattacharya Nandita | 3 |
#9 | Goukassian David A | 2 |
Publication | Filing date | Title |
---|---|---|
WO2016007945A1 | Compositions and methods for treating or preventing cardiac hypertrophy | |
US2015140009A1 | Compositions and methods for the treatment of radiation exposure | |
CA2887642A1 | Compositions and methods for auditory therapy | |
WO2014055949A1 | Platelet compositions and uses thereof | |
WO2014031649A1 | Compositions and methods for treating or preventing anthracycline induced cardiotoxicity |